MedTrace Logo

Treatment of Adults With Generalized Anxiety Disorder Using Glutamine

NCT04274114 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2021-02-11

No results posted yet for this study

Summary

The objective of this randomized clinical trial is to examine the efficacy of L-glutamine for the treatment of generalized anxiety disorder compared versus placebo.

Conditions

  • Generalized Anxiety Disorder

Interventions

DRUG

L Glutamine

Powder

DRUG

Placebos

Powder

Sponsors & Collaborators

  • Instituto de Información e Investigación en Salud Mental A. C.

    collaborator UNKNOWN

  • Hospital Universitario Dr. Jose E. Gonzalez

    lead OTHER

Principal Investigators

  • José A Ontiveros Sánchez De la Barquera, MD, PhD · Hospital Universitario Dr. Jose E. Gonzalez

  • Luis A Centeno Gándara, MD · Hospital Universitario Dr. Jose E. Gonzalez

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-18
Primary Completion
2020-05-12
Completion
2020-05-12

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04274114 on ClinicalTrials.gov